Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07329673Recruiting

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

Role: lead

NCT07220330Enrolling By Invitation

An Investigational Study Examining the Cross-Validation of QbMobile in ADHD and Normative Populations

Role: lead

NCT07217977Enrolling By Invitation

An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD

Role: lead

NCT07330960Not Yet Recruiting

Augmenting Existing Normative Data for QbMobile in Healthy Children Aged 6-11 Years

Role: lead

All 4 trials loaded